nothing unusual with medicine approval process with FDA. sentiment changes but fundamentally speaking , it is all about right track.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren approaching key milestones in Q4 2019
Ann: Neuren approaching key milestones in Q4 2019, page-32
-
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.34 |
Change
-0.445(2.14%) |
Mkt cap ! $2.656B |
Open | High | Low | Value | Volume |
$20.50 | $20.66 | $20.01 | $932.5K | 45.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30 | $20.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.36 | 180 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9 | 20.510 |
3 | 190 | 20.500 |
3 | 178 | 20.490 |
3 | 254 | 20.480 |
3 | 196 | 20.470 |
Price($) | Vol. | No. |
---|---|---|
20.560 | 30 | 2 |
20.570 | 302 | 4 |
20.580 | 265 | 5 |
20.590 | 152 | 2 |
20.600 | 154 | 2 |
Last trade - 10.26am 19/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |